Evangelos J. Giamarellos-Bourboulis, Garyfallia Poulakou, Aline de Nooijer, Haralampos Milionis, Simeon Metallidis, Michalis Ploumidis, Pinelopi Grigoropoulou, Aggeliki Rapti, Francesco Vladimiro Segala, Evangelos Balis, Efthymia Giannitsioti, Paola Rodari, Ilias Kainis, Zoi Alexiou, Emanuele Focà, Brollo Lucio, Nikoletta Rovina, Laura Scorzolini, Maria Dafni, Sofia Ioannou, Alessandro Tomelleri, Katerina Dimakou, Glykeria Tzatzagou, Maria Chini, Matteo Bassetti, Christina Trakatelli, George Tsoukalas, Carlo Selmi, Charilaos Samaras, Maria Saridaki, Athina Pyrpasopoulou, Elisabeth Kaldara, Ilias Papanikolaou, Aikaterini Argyraki, Karolina Akinosoglou, Marina Koupetori, Periklis Panagopoulos, George N Dalekos, Mihai G Netea
Cell Reports Medicine 2022 Feb 25;3(3):100560
DOI: 10.1016/j.xcrm.2022.100560
Funding
The study was funded in part by the Hellenic Institute for the Study of Sepsis and by Swedish Orphan Biovitrum. The Hellenic Institute for the Study of Sepsis is the sponsor of the SAVE and SAVE-MORE studies.
SCOPE score calculator: mobile & desktop application
Keywords: C-reactive protein; COVID-19; D dimers; SARS-CoV-2; biomarkers; disease progression; ferritin; interleukin-6; soluble urokinase plasminogen activator receptor
Related Studies: SAVE-MORE, SAVE